@article{32d1812282344d45b37de979cc71cf59,
title = "A randomized controlled trial protocol for people with traumatic brain injury enrolled in a healthy lifestyle program (GLB-TBI)",
abstract = "Weight gain is prevalent among people with traumatic brain injury (TBI) and may be attributable to environmental or injury-specific factors such as mobility impairment, endocrine dysfunction, behavioral and emotional disorders, and sensory loss. Few weight management programs exist to meet the unique needs of this population. Researchers modified a nationally recognized, evidence-based weight-loss program, Group Lifestyle Balance{\texttrademark} (GLB), to address the needs of over-weight and obese people post TBI (GLB-TBI). This current randomized controlled trial (RCT) examines the efficacy of the GLB-TBI on weight and secondary outcomes compared to an attention control educational support group. Furthermore, researchers have developed a mobile technology app to further engage participants in the program. This RCT will enroll and randomize 66 participants over a two-year period. It is anticipated that findings from this current RCT will contribute to the knowledge and evidence for an effective weight-loss intervention among this underserved population, with a goal of achieving full recognition by the Centers for Disease Control and Prevention-National Diabetes Prevention Program and subsequent Center for Medicare and Medicaid Services reimbursement for participation.",
keywords = "Intervention, Nutrition, Physical activity, Rehabilitation, Weight loss",
author = "Simon Driver and Shannon Juengst and McShan, {Evan Elizabeth} and Monica Bennett and Kathleen Bell and Rosemary Dubiel",
note = "Funding Information: The contents of this publication were developed under a grant from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR grant number 90DPTB0013-01-00 ). NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this publication do not necessarily represent the policy of NIDILRR, ACL, or HHS, and you should not assume endorsement by the Federal Government. Funding Information: Based on positive findings from our pilot work [45], participants in both groups will also have the option to join a closed Facebook page to facilitate group cohesion and peer support, ask each other questions, share challenges and successes, provide encouragement, and share resources.Traumatic brain injury continues to be the leading cause of injury-related death and disability in the United States (US) [73]. More than 5.3 million people in the US currently live with TBI-related disability [74] and increasingly TBI is considered a chronic health condition rather than a single event [75,76]. Individuals with TBI also experience related secondary conditions such as weakness, impaired mobility, sensory loss, impaired cognition, and emotional or behavioral disorders, often then leading to further chronic conditions such as diabetes, heart disease, and hypertension [77]. Though evidence exists to support the impact of a healthy lifestyle on weight loss and reduction of secondary conditions such as diabetes, heart disease and hypertension, few studies exist to promote a healthy lifestyle post TBI [78–80]. Therefore, there is a critical need to address these barriers and modify evidence-based weight loss interventions to meet the unique needs of people with TBI.The contents of this publication were developed under a grant from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR grant number 90DPTB0013-01-00). NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this publication do not necessarily represent the policy of NIDILRR, ACL, or HHS, and you should not assume endorsement by the Federal Government. Publisher Copyright: {\textcopyright} 2019 The Authors",
year = "2019",
month = jun,
doi = "10.1016/j.conctc.2019.100328",
language = "English (US)",
volume = "14",
journal = "Contemporary Clinical Trials Communications",
issn = "2451-8654",
publisher = "Elsevier Inc.",
}